Facial Implant Market Size, Share & Trends Analysis Report By Product (Chin And Mandibular, Cheek, Nasal, Injectable), By Material (Metal, Biologics), By Procedure (Eyelid, Facelift, Rhinoplasty), By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global facial implant market size was valued at USD 2.48 billion in 2021 and is expected to expand at a CAGR of 8.2% from 2022 to 2030. The facial implant is a kind of medical device that is used in correcting the facial structure or to offer more defined facial characteristics including chin, cheeks, and jawline. The rising virtual representation on social media is expected to fuel the demand of the facial implants market throughout the forecast period. Moreover, the growing concern regarding personal appearance among the local population in both developed and developing countries is projected to increase the number of cosmetic surgeries, this factor is expected to propel the growth of the market.

市场预计将显示一个向上的转变during the forecast period due to the growing concern for physical and aesthetic appearance across all age groups and the increasing adoption of cosmetic procedures driving the demand for plastic surgeries globally. In addition, associated advantages such as painless procedure, safety and efficacy, less recovery time, and less hospital stay are the factors expected to fuel the demand for invasive aesthetic surgery over the forecast period. Furthermore, the increasing cases of facial deformities due to congenital disorders, trauma requiring cosmetic surgery are further expected to fuel the demand for a facial implant over the forecast period.

COVID-19大流行造成了巨大的破坏in the supply chain of the overall medical device industry. The outbreak has resulted in a decrease in the number of procedures performed each year, resulting in an overall decline in the market. The outbreak of coronavirus has impacted the market negatively as there was a decline in the number of procedures in 2020 and 2021 due to global restrictions. American Society for Aesthetic Plastic Surgeons saw an overall 15% decline in the total number of cosmetic procedures in 2020 due to the COVID-19 pandemic. The rising adoption of cosmetic surgeries among celebrities and increasing awareness regarding facial implants are expected to propel the growth of the facial implant market. However, complications associated with the surgeries, like excessive bleeding after facial implant procedures and chances of success rate could hamper the growth of the market.

Product Insights

下巴,下颌段控制目标et and accounted for the largest revenue share of 30.3% in 2021. The segment was valued at USD 2,487.6 million in terms of revenue in 2021. Increasing chin augmentation procedures for facial rejuvenation and rising adoption rate are the factors attributing to its dominance over the forecast period. The surgery involves the placement of an implant around an individual’s existing chin bone to augment its shape and size. Chin enhancement surgery can provide a permanent solution to improve a recessed or weak chin.

However, the fillers or injectables segment is anticipated to register a lucrative CAGR of over 8.6% in the coming years owing to the increasing demand for cost-effectiveness, nonsurgical facial rejuvenation procedures, and growing awareness pertaining to the use of fillers for augmentation surgery. Facial injectables such ashyaluronic acidand botulinum toxin were among the most popular products among females. The segment is likely to grow due to the increasing use of facial fillers for aesthetic procedures such as wrinkles on the face, facial lines, lip lines, and others.

Material Insights

The polymer segment dominated the market and accounted for the largest revenue share of 37.3% in 2021. Polymer material dominated the market in terms of revenue as of 2021 due to the increasing usage for deformity correction surgeries. Polymeric materials have considerable tensile strength and are best suited for facial implants. Furthermore, other benefits associated with it including flexibility, rigid support, and biocompatibility are anticipated to fuel the market growth. The most frequently used implants are solid silicone implants that are used for augmentation surgery.

The biologicals segment is expected to witness the most lucrative CAGR during the forecast period owing to the greater resemblance to the body tissues enabling easy adoption. Furthermore, the increasing investments in the R&D of biocompatible implant manufacturing are also projected to propel market growth in the future.

Procedure Insights

The eyelid segment dominated the market and accounted for the largest revenue share of 39.3% in 2021. The number of procedural implants is expected to rise due to the rising demand for facial surgeries globally. Eyelid surgery held the largest share in 2021 owing to the increasing number of aesthetic procedures for reducing bagginess, correcting vision, and removing extra skin from eyelids. Eyelid surgery or blepharoplasty is a long-term procedure, the outcomes of which the patient can enjoy for many years, hence the number of procedures performed globally constantly growing.

Eyelid surgeryis painless, performed under local anesthesia, and lasts up to an hour. Immediately after the procedure, the patient is free to go home. All these factors are also boosting the eyelid surgery segment market growth. According to ASPS, about 352,112 eyelids and 234,374 facelift procedures were performed in the U.S.in 2020 and are expected to grow over the forecast period. Facelift surgery is projected to gain pace in the coming years due to the growing awareness of aesthetics, especially in baby boomers. According to the stats published by The American Society of Plastic Surgeons (ASPS), nose reshaping facelift and eyelid surgery was the topmost cosmetic surgery performed in the U.S. in 2020.

Regional Insights

North America dominated the market and accounted for the largest revenue share of over 49.2% in 2021 owing to the rising cases of facial distortion due to extensive commercialization. Furthermore, high patient awareness levels, the innovation of technologically advanced facial implants, rising demand for minimally invasive surgeries, and the presence of advanced healthcare infrastructure for facial procedures are some other driving factors for the regional market growth. The rising focus on facial aesthetics and the need to become young among the population is also anticipated to increase the demand for facial surgeries in the coming years.

In Asia Pacific, the market is expected to witness the highest CAGR during the forecast period. The presence of high untapped opportunities, economic development, rising patient awareness levels, and constantly improving healthcare infrastructure are some key factors driving the Asia Pacific market. In addition, increasing medical tourism activities supported by low procedural costs in the emerging economies of India and China are expected to drive industry growth over the next seven years.

Key Companies & Market Share Insights

Key companies have established key business strategies such as strategic partnerships and collaborations, product innovation, joint ventures, new product launches, new service launches, and contracts to build their market position along with gaining popularity in the market. The market is competitive in nature as key players are engaged in rigorous R&D to develop efficient and cost-effective products for reconstructive surgery and trauma treatment. For instance, in November 2021 U.S. Oral Surgery Management (USOSM) - a specialty management services company that exclusively provides premier oral and maxillofacial specialists entered into a new partnership with the Center for Facial, Oral, and Implant Surgery.

Furthermore, in February 2022, Zimmer Biomet and Bactiguard have agreed to expand the global license agreement that was started in 2019, to cover a range of implant product segments to prevent post-operative infections. The exclusive license partnership includes implants for sports medicine, joint reconstruction (hips and knees), craniomaxillofacial and thoracic applications. Some of the prominent players in the facial implant market include:

• Zimmer Biomet

• Depuy Synthes

• Stryker Corp.

• Medartis AG

• EUROS

• Xilloc

• KLS Martin Group

• Hanson Medical, Inc.

• Integra LifeSciences

• OsteoMed

• Sientra Inc

• Kangui Medical Innovation Co. Ltd.

• AART Inc.

• Anthony Products Inc

• W.L. Gore & Associates, Inc.

• Spectrims Design Medicals Inc.

• Lucid Implants

• Johnson & Johnson

• TMJ Concepts

• Sebbin

Facial Implant Market Report Scope

Report Attribute	Details
Market size value in 2022	USD 2.7 billion
Revenue forecast in 2030	USD 4.6 billion
Growth rate	CAGR of 8.2% from 2022 to 2030
Base year for estimation	2021
Historical data	2018 - 2020
Forecast period	2022 - 2030
Quantitative units	Revenue in USD million and CAGR from 2022 to 2030
Report coverage	Revenue forecast, company share, competitive landscape, growth factors and trends
Segments covered	Product, material, procedure, shape, gender, end user, region
Regional scope	North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country scope	U.S.; Canada; U.K.; Germany; Italy; France; Spain; China; Japan; India; Australia; South Korea; Brazil; Mexico; South Africa; Saudi Arabia
Key companies profiled	Zimmer Biomet; Depuy Synthes; Stryker; Medartis AG; EUROS; Xilloc; KLS Martin Group; Hanson Medical, Inc.; Integra LifeSciences; OsteoMed; Sientra Inc; Kangui Medical Innovation Co. Ltd.; AART Inc.; Anthony Products Inc; W.L. Gore & Associates, Inc.; Spectrims Design Medicals Inc.; Lucid Implants; Johnson & Johnson; TMJ Concepts; Sebbin
Customization scope	Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional, and segment scope.
革命制度党cing and purchase options	Avail customized purchase options to meet your exact research needs.Explore purchase options.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global facial implant market report on the basis of product, material, procedure, shape, gender, end user, region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Chin and Mandibular

  • Cheek

  • Nasal

  • Injectables

• Material Outlook (Revenue, USD Million, 2018 - 2030)

  • Metal

  • Biologicals

  • Polymers

  • Ceramic

• Procedure Outlook (Revenue, USD Million, 2018 - 2030)

  • Eyelid Surgery

  • Facelift

  • Rhinoplasty

• Shape Outlook (Revenue, USD Million, 2018 - 2030)

  • Anatomical Facial Implants

  • Oval Facial Implants

  • Round Facial Implants

• Gender Outlook (Revenue, USD Million, 2018 - 2030)

  • Male

  • Female

• End User Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Trauma Center

  • Specialty Clinics

  • Ambulatory Surgical Centers

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • Italy

    • France

    • Spain

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa

    • Saudi Arabia